Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Kim, Jin Koo  [Clear All Filters]
2013
Jung Y, Kim JKoo, Shiozawa Y, Wang J, Mishra A, Joseph J, Berry JE, McGee S, Lee E, Sun H, et al. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun. 2013;4:1795.
Kim JKoo, Jung Y, Wang J, Joseph J, Mishra A, Hill EE, Krebsbach PH, Pienta KJ, Shiozawa Y, Taichman RS. TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition. Neoplasia. 2013;15(9):1064-74.
2018
Kramer K, Yang J, W Swanson B, Hayano S, Toda M, Pan H, Kim JKoo, Krebsbach PH, Mishina Y. Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model. Genesis. 2018;56(6-7):e23220.
2019
Nguyen JTruong, Haidar FSarah, Fox ALucienne, Ray C, Mendonça DBaccelli, Kim JKoo, Krebsbach PH. mEAK-7 Forms an Alternative mTOR Complex with DNA-PKcs in Human Cancer. iScience. 2019;17:190-207.
2020
Jung Y, Kim JKoo, Lee E, Cackowski FC, Decker AM, Krebsbach PH, Taichman RS. CXCL12γ induces human prostate and mammary gland development. Prostate. 2020.
2021
Wang C, Li Y, Jia L, Kim JKoo, Li J, Deng P, Zhang W, Krebsbach PH, Wang C-Y. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell. 2021.
2023
Kim JKoo, Villa-Diaz LG, Saunders TL, Saul RP, Timilsina S, Liu F, Mishina Y, Krebsbach PH. Selective Inhibition of mTORC1 Signaling Supports the Development and Maintenance of Pluripotency. Stem Cells. 2023.